NOAH’s second Brexit Barometer report has revealed that animal medicines businesses are becoming increasingly concerned about the future of the industry post-Brexit.

Increasing levels of complexity and a lack of Government progress overall were found to be key contributors to the rising concerns. However, the findings revealed that despite an increase in levels of uncertainty compared to the previous Brexit Barometer in May 2017, the industry is by no means losing hope.

The changing sentiment was tracked across the same six lenses: animal health and welfare, public health and food production, trade and investment, R&D and innovation, bringing new products to market and post-licensing controls for the overall market.

NOAH chief executive Dawn Howard said: “Our second Brexit Barometer report paints a picture of growing uncertainty, which we as an industry need to address. Whilst Government progress is a major contributor to the rising concerns, we cannot be complacent and simply wait for action from Government.

“Recognising key areas of concern is of paramount importance so that we are ready to take action to achieve success within these areas. Safeguarding a skilled workforce, championing the UK jobs market and looking ahead to what may be in store with regard to regulatory changes and licensing frameworks are all possible even at this early stage.

“We will continue to work closely with our members and stakeholders to ensure that we make Brexit as successful as we possibly can for the animal medicines industry.”

The third Brexit Barometer will be launched in the Summer.